Texas Yale Capital Corp.
Source: SEC Form 13F · as of Mar 2026Texas Yale Capital Corp. holds 22 biotech & pharma companies tracked by BioSniper, totaling $60.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$60.7M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 47,107 | $10.2M |
| JNJJOHNSON & JOHNSON | 35,832 | $8.8M |
| SUNSUNSET ISLAND GROUP | 133,146 | $8.7M |
| MRKMerck & Co., Inc. | 58,188 | $7.0M |
| LLYELI LILLY & Co | 5,744 | $5.3M |
| AMGNAMGEN INC | 10,247 | $3.6M |
| PMPhilip Morris International Inc | 21,523 | $3.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 9,238 | $2.5M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 4,344 | $1.9M |
| MCKMcKesson Corporation | 2,213 | $1.9M |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,924 | $1.5M |
| ABTABBOTT LABORATORIES | 12,615 | $1.3M |
| NVONovo Nordisk A/S | 22,324 | $820K |
| BIIBBIOGEN INC. | 3,987 | $731K |
| NVSNovartis AG | 4,392 | $671K |
| PBHPrestige Consumer Healthcare Inc. | 9,485 | $562K |
| BMYBRISTOL MYERS SQUIBB CO | 8,050 | $488K |
| CORCencora Inc. | 1,155 | $363K |
| GILDGILEAD SCIENCES, INC. | 2,135 | $298K |
| GMOptec International, Inc. | 3,225 | $240K |
| CAHCardinal Health Inc. | 1,078 | $228K |
| CRMDCorMedix Inc. | 16,000 | $109K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.